Ignite Creation Date:
2024-05-06 @ 9:20 AM
Last Modification Date:
2024-10-26 @ 12:13 PM
Study NCT ID:
NCT02959619
Status:
COMPLETED
Last Update Posted:
2023-08-21
First Post:
2016-11-06
Brief Title:
Ensartinib in Non-small Cell Lung Cancer Patients With Positive ALK
Sponsor:
Betta Pharmaceuticals Co Ltd
Organization:
Betta Pharmaceuticals Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-03-06
Start Date Type:
ACTUAL
Primary Completion Date:
2019-10-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-04-23
Completion Date Type:
ACTUAL
First Submit Date:
2016-11-06
First Submit QC Date:
November 7 2016
Study First Post Date:
2016-11-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-15
Last Update Post Date:
2023-08-21
Last Update Post Date Type:
ACTUAL